Resmed (RMD)
NYSE:RMD

Resmed (RMD) Stock Price & Analysis

698 Followers

RMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$192.79 - $245.73
Previous Close$220.64
Volume413.75K
Average Volume (3M)596.44K
Market Cap
$32.42B
Enterprise Value$33.91B
Total Cash (Recent Filing)$227.89M
Total Debt (Recent Filing)$1.72B
Price to Earnings (P/E)37.6
Beta0.95
Aug 03, 2023
1.76 (0.79%)
Share Statistics
EPS (TTM)5.86
Shares Outstanding146,930,660
10 Day Avg. Volume949,100
30 Day Avg. Volume596,437
Standard Deviation0.08
R-Squared0.11
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)53.66
Price to Sales (P/S)29.03
Price to Cash Flow (P/CF)27.40
P/FCF Ratio27.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.37
Enterprise Value/Gross Profit9.48
Enterprise Value/Ebitda36.36
Forecast
Price Target Upside19.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

RMD FAQ

What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $192.79 and its highest was $245.73 in the past 12 months.
    What is Resmed’s market cap?
    Currently, no data Available
    When is Resmed’s upcoming earnings report date?
    Resmed’s upcoming earnings report date is Aug 03, 2023 which is in 58 days.
      How were Resmed’s earnings last quarter?
      Resmed released its earnings results on Apr 27, 2023. The company reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.592 by $0.088.
        Is Resmed overvalued?
        According to Wall Street analysts Resmed’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Resmed pay dividends?
          Resmed pays a Quarterly dividend of $0.44 which represents an annual dividend yield of 0.8%. See more information on Resmed dividends here
            What is Resmed’s EPS estimate?
            Resmed’s EPS estimate is $1.68.
              How many shares outstanding does Resmed have?
              Resmed has 146,930,660 shares outstanding.
                What happened to Resmed’s price movement after its last earnings report?
                Resmed reported an EPS of $1.68 in its last earnings report, beating expectations of $1.592. Following the earnings report the stock price went up 6.951%.
                  Which hedge fund is a major shareholder of Resmed?
                  Among the largest hedge funds holding Resmed’s share is Alecta Pensionsforsakring, Omsesidigt. It holds Resmed’s shares valued at 108M.

                    ---

                    Resmed Stock Smart Score

                    The Resmed stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Resmed

                    Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).

                    ---

                    Top 5 ETFs holding RMD

                    Name
                    Market Value
                    Smart Score
                    Vanguard S&P 500 ETF
                    $830.86M
                    8
                    SPDR S&P 500 ETF Trust
                    $362.93M
                    8
                    SPDR S&P 500 ETF Trust CDI
                    $362.93M
                    8
                    Vanguard Growth ETF
                    $301.47M
                    8
                    iShares Core S&P 500 ETF
                    $286.88M
                    8
                    Up to five ETFs with an Outperform Smart Score that hold RMD. The ETFs are listed according to market value of RMD within the ETF

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Conmed
                    Haemonetics
                    Nevro Corp
                    Align Tech

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis